Showing results (1101-1110 of 1,892) with videos related to

Sort By:
Pageof 190
Immunotherapy|August 6, 2024
A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 studyShobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, et al.
Immunotherapy|July 29, 2024
The role of dupilumab in the treatment of eosinophilic esophagitisErin P Syverson, Eitan Rubinstein, John J Lee, et al.
Immunotherapy|January 9, 2023
Sintilimab combined with chemotherapy successfully treated a patient with advanced submandibular gland tumorYingfang Zhang, Min Zhang, Jing Zhang, et al.
Immunotherapy|January 9, 2023
Update on immunotherapy in the management of gallbladder cancerJoseph Kassab, Ludovic Saba, Georges Gebrael, et al.
Immunotherapy|January 25, 2023
Poor response to sintilimab plus chemotherapy in a pulmonary epithelioid hemangioendothelioma patient: a case reportHao Zeng, Xiaojun Tang, Xia Tian, et al.
Immunotherapy|January 25, 2023
Hypertransaminasemia in metastatic renal cell carcinoma patients receiving immune-based combinations: a meta-analysisAlessandro Rizzo, Giacomo Nuvola, Gennaro Palmiotti, et al.
Immunotherapy|November 24, 2022
A case report of pulmonary nocardiosis during pembrolizumab: the emerging challenge of the infections on immunotherapyAngioletta Lasagna, Bryan Arlunno, Ilaria Imarisio
Immunotherapy|November 19, 2019
Cost-effectiveness of pembrolizumab versus chemotherapy as first-line treatment in PD-L1-positive advanced non-small-cell lung cancer in the USAMin Huang, Gilberto de Lima Lopes, Ralph P Insinga, et al.
Immunotherapy|November 6, 2019
Reslizumab and mepolizumab for moderate-to-severe poorly controlled asthma: an indirect comparison meta-analysisKevin Yan, Chakrapani Balijepalli, Rohini Sharma, et al.
Immunotherapy|July 8, 2021
TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseasesMaciej Gonciarz, Katarzyna Pawlak-Buś, Piotr Leszczyński, et al.
Pageof 190